scholarly journals Effects of Gadolinium Contrast Agent Administration on Automatic Brain Tissue Classification of Patients with Multiple Sclerosis

2014 ◽  
Vol 35 (7) ◽  
pp. 1330-1336 ◽  
Author(s):  
J.B.M. Warntjes ◽  
A. Tisell ◽  
A.-M. Landtblom ◽  
P. Lundberg
Keyword(s):  
Multiple Sclerosis ◽  
Contrast Agent ◽  
Brain Tissue ◽  
Tissue Classification ◽  
Gadolinium Contrast ◽  
Gadolinium Contrast Agent ◽  
Contrast Agent Administration

scholarly journals Quantification of amide proton transfer effect pre- and post-gadolinium contrast agent administration

2013 ◽  
Vol 40 (4) ◽  
pp. 832-838 ◽  
Author(s):  
Yee Kai Tee ◽  
Manus J. Donahue ◽  
George W.J. Harston ◽  
Stephen J. Payne ◽  
Michael A. Chappell
Keyword(s):  
Proton Transfer ◽  
Contrast Agent ◽  
Transfer Effect ◽  
Amide Proton ◽  
Gadolinium Contrast ◽  
Amide Proton Transfer ◽  
Gadolinium Contrast Agent ◽  
Contrast Agent Administration

Evaluation of an albumin-binding gadolinium contrast agent in multiple sclerosis

Neurology ◽  
2013 ◽  
Vol 81 (3) ◽  
pp. 206-210 ◽  
Author(s):  
S. Kremer ◽  
J. Lamy ◽  
A. Magnus ◽  
H. Oesterle ◽  
J. Jeantroux ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Contrast Agent ◽  
Albumin Binding ◽  
Gadolinium Contrast ◽  
Gadolinium Contrast Agent

Gadolinium contrast agent is of limited value for magnetic resonance imaging assessment of synovial hypertrophy in hemophiliacs

2007 ◽  
Vol 48 (5) ◽  
pp. 520-530 ◽  
Author(s):  
B. Lundin ◽  
E. Berntorp ◽  
H. Pettersson ◽  
R. Wirestam ◽  
K. Jonsson ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Contrast Agent ◽  
Dynamic Mri ◽  
Time Interval ◽  
Resonance Imaging ◽  
Mri Findings ◽  
Gadolinium Contrast ◽  
Synovial Hypertrophy ◽  
Gadolinium Contrast Agent

Purpose: To examine the influence of different doses of gadolinium contrast agent on synovial enhancement, to compare magnetic resonance imaging (MRI) findings of synovial hypertrophy and radiographic joint changes in hemophiliacs, and to investigate the value of gadolinium in MRI assessment of synovial hypertrophy in hemophiliacs using dynamic MRI and MRI scoring. Material and Methods: Twenty-one hemophiliacs on prophylactic factor treatment without recent bleeds were subjected to radiography and gadolinium contrast-enhanced dynamic and static MRI of the knee using a standard dose of 0.1 mmol/kg b.w. gadoteridol. In 17 of the patients, the MRI procedure was repeated after a triple dose of gadoteridol. Results: MRI findings of synovial hypertrophy were significantly correlated with Pettersson radiographic scores. In 19 of the 21 MRI investigated joints, administration of contrast agent did not alter the result of the evaluation of synovial hypertrophy. Conclusion: The optimal time interval for volume assessment of synovial hypertrophy after injection of gadolinium contrast agent is dose dependent. Hemophiliacs without recent bleeds have minor to abundant synovial hypertrophy in joints with pronounced radiographic changes. Dynamic MRI is not useful for evaluating hemophilic arthropathy, and gadolinium contrast agent is not routinely indicated for MRI scoring of joints in hemophiliacs.

Sign in / Sign up

Export Citation Format

Share Document